OPTIDRIL 30 micrograms/150 micrograms, film-coated tablet 21 tablets
Active ingredients: Levonorgestrel, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet21 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OPTIDRIL 30 microgrammes/150 microgrammes, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 plaquette(s) PVC PVDC aluminium de 21 comprimé(s) - 1 plaquette(s) PVC PVDC aluminium de 7 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES MAJORELLE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63071085CIP72675251CIP133400926752514Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVONORGESTRELcomprimé jaunâtre | 150 microgrammes · un comprimé | SA |
| ÉTHINYLESTRADIOLcomprimé jaunâtre | 30 microgrammes · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.